About Helix
Helix is a Healthcare company based in San Francisco (United States) founded in 2015 by James Lu. Genomic database for clinical research is provided. It operates on a Data-as-a-Service, Professional Services, and HealthTech model. Helix has raised $435 million across 4 funding rounds from investors including Illumina, Kleiner Perkins and NIH. Its chief executive, as recorded, is James Lu. Its website helix.com draws about 181 thousand monthly visits. Helix offers products and services including Helix Research Network, Helix Precision Pathway, Helix Diagnostics, Helix Genomic Advantage, and Helix GenoSphere. Its focus areas include Biotechnology and Genomics. Its legal entity is Helix, Inc. Its competitors include 23andMe, Benchling and Genuity Science; 3 of its 3 listed competitors have raised funding.
Company details
Helix is established as a leading enterprise genomics platform that transforms health and life-science organizations by leveraging genomic insights. Solutions are provided across sectors like health systems, providers, life sciences, and payers. Genomic intelligence is utilized to advance precision medicine, enhance patient care, and drive innovation in healthcare. Strategic growth is supported through expanded precision medicine capabilities, improved health outcomes, and diversified revenue streams. Healthcare economics are transformed by identifying high-risk populations and enabling targeted interventions.
- Total Equity Funding$435M (USD)
in 4 rounds
- Latest Funding Round$50M (USD), Series C
Jun 2021
- InvestorsIllumina
& 8 more
Products & Services of Helix
Helix offers a comprehensive portfolio of products and services, including Helix Research Network, Helix Precision Pathway, Helix Diagnostics, Helix Genomic Advantage, and Helix GenoSphere.
Genomic discoveries are accelerated for clinical impact.
Clinical decisions are enhanced with genomic insights.
Comprehensive genomic insights are provided for patients.
Healthcare costs are reduced for health plans.
Clinico-genomic cohorts are accessed for drug innovation.
Funding Insights of Helix
Helix has successfully raised a total of $435M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $50 million completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $435M
- Total Rounds 4
- Last Round Series C — $50M
- First Round $185M
(Apr 2017)
- Investors Count 9
All 4 funding rounds of Helix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2021 | $50M | Series C | – | Warburg Pincus, DFJ Growth | – |
| Jul 2020 | $33M | Grant | – | – | |
| Mar 2018 | $200M | Series B | – | DFJ Growth | |
| Apr 2017 | $185M | Series A | – | Warburg Pincus, Sutter Hill Ventures |
9 investors in total: 9 institutional.
Investors in Helix
Helix has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Illumina, Kleiner Perkins and NIH.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Multi-stage private equity investments are pursued across diverse sectors. | 1966 | warburgpincus.com | New York, United States | |
Investments are directed toward innovative technology startups by DFJ Growth. | dfjgrowth.com | Menlo Park, United States | ||
Venture capital firm investing in early-stage tech startups | 1972 | kleinerperkins.com | Menlo Park, United States | |
An investment platform is provided for diverse sectors and geographies. | 1974 | temasek.com.sg | Singapore, Singapore | |
VC firm investing in the US | shv.com | Palo Alto, United States | ||
Healthcare startups are accelerated by Mayo Clinic Business Accelerator. | mcbusaccel.com | Rochester, United States | ||
General medical clinics are operated throughout the United States. | 1864 | mayoclinic.org | United States | |
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States | |
Developer of technologies for analysis of genetic variation and function | 1993 | illumina.com | San Diego, United States |
Investor details for Helix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Helix
104 people are tracked at Helix (31 in leadership, 3 in board & advisors, 70 in team).
| Name | Role | Group |
|---|---|---|
James Lu | Co-Founder & CEO | Leadership |
Sarah Bobulsky | CFO & COO | Leadership |
Daniel Montoya | Director, IT | Leadership |
Will Lee | Svp, Chief Science Officer | Leadership |
Moosa Choudhry | Director of Engineering, Platform | Leadership |
Sharoni Jacobs | Senior Director of Product, Science | Leadership |
Ariana Lichtenstein | Regional Vice President, Life Sciences | Leadership |
Scott Malony | Head Of Supply Chain | Leadership |
Jimmy M. Ramirez III | Associate Director, Lab Operations | Leadership |
Efren Sandoval | Vice President Operations | Leadership |
Bianca Lin | Head Of Strategy | Leadership |
Emre Colak | Director Of Engineering | Leadership |
John Pfeiffer | Engineering Director | Leadership |
Ryan N. | Head Of Security | Leadership |
Maya Ziv | Associate Legal Director, Commercial | Leadership |
Bryan S. | Senior Director, Finance | Leadership |
Natalie Schulz | Senior Human Resources Business Partner | Leadership |
Jim Chou | CTO | Leadership |
Cassie Hajek | Medical Director | Leadership |
Charlie Coe | VP - Precision Pathway | Leadership |
84 more people are available in the full profile.
Complete people profiles for Helix
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Helix
3 dated milestones of Helix across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Helix is founded.
- Funding First funding round of $185.0M.
- Funding Latest funding round, Series C, of $50.0M.
Competitors of Helix
Helix has 3 listed competitors in our database, 3 of them funded. They include 23andMe, Benchling and Genuity Science.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| 23andme.com | 2006 | Sunnyvale, United States | $943.53M | 755 | Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | |
| benchling.com | 2012 | San Francisco, United States | $411.9M | 640 | Cloud-based bioinformatics platform is offered for biotech research. | |
| genuitysci.com | 2013 | Boston, United States | $515M | AI-based omics data analysis solutions are provided to researchers. |
Detailed competitors of Helix
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Helix
The website of Helix (helix.com) receives about 180.6K visits a month.
- Monthly visits180.6K
▼ 3.5% vs previous month
Websites whose visitors overlap most with Helix. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| nytimes.com | 100% | 695.1M | #71 | View details | |
| msn.com | 95% | #74 | View details | ||
| cnn.com | 94% | 494.3M | #131 | View details | |
| journalgazette.net | 85% | 680.7K | #339,026 | View details | |
| helixsleep.com | 45% | 837.1K | #56,350 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 11 similar websites and full traffic analytics for Helix
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 11 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Helix (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Helix
Complete news archive for Helix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Helix
Helix was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Helix is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
James Lu is the CEO of Helix, as recorded in our data. They have also founded this company.
Helix is a funded company, having raised a total of $435M across 4 funding rounds to date. The company's 1st funding round was a Series A of $185M, raised on Apr 2017.
Helix is established as a leading enterprise genomics platform that transforms health and life-science organizations by leveraging genomic insights. Solutions are provided across sectors like health systems, providers, life sciences, and payers. Genomic intelligence is utilized to advance precision medicine, enhance patient care, and drive innovation in healthcare. Strategic growth is supported through expanded precision medicine capabilities, improved health outcomes, and diversified revenue streams. Healthcare economics are transformed by identifying high-risk populations and enabling targeted interventions.
Helix's top competitors include 23andMe, Benchling and Genuity Science.
Helix offers Helix Research Network, Helix Precision Pathway, Helix Diagnostics, Helix Genomic Advantage, and Helix GenoSphere.
Helix has 9 investors. Key investors include Illumina, Kleiner Perkins, NIH, Mayo Clinic, and Warburg Pincus.
Helix operates through Helix, Inc..
The website of Helix receives about 181 thousand visits a month.